Searched for
BIOCON STOCK
BSE, RIL, Paytm among stocks bought and sold by HDFC Mutual Fund in JulyJuly was a busy month for HDFC Mutual Fund, which ramped up its investments by increasing its stakes in about 422 stocks. Simultaneously, t...- Biocon shares rise 2% after USFDA approval for Yesintek single-dose prefilled autoinjectorBiocon shares rose after its US subsidiary received supplemental FDA approval for Yesintek single-dose prefilled autoinjectors in two stren...
- Cochin Shipyard and Patanjali Foods among top 5 midcap stocks that saw highest mutual fund buying in JulyMutual funds increased buying in five midcap stocks during July, led by Rail Vikas, Cochin Shipyard, Patanjali Foods, Biocon and Tata Elxsi...
- INDO-MIM, Ather Energy and TCS among stocks bought and sold by mutual funds in JulyMutual funds bought Rs 15,900 crore of stocks in July while FIIs sold Rs 11,000 crore. Axis Bank, INDO-MIM and Kotak Mahindra Bank saw majo...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Buy, Sell or Hold: Goldman Sachs maintains buy rating on Jindal Stainless; Citi recommends sell call on BioconIGI: Morgan Stanley stays bullish, citing strong certification-market growth and the company’s shift toward a consumer-focused business.Jin...
- Q1 earnings this week: SBI, Trent, Nykaa among 573 companies set to announce June quarter resultsThis week, 573 companies will announce their June quarter results, featuring prominent firms. Bharti Airtel and Nykaa are among those repor...
- Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investorsDonald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analys...
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
- MSCI India rejig: Eternal likely to see highest inflows at $648 mn; Lenskart, Groww among Nuvama’s expected inclusionsMSCI’s August India Standard Index review could trigger major passive inflows, with Eternal expected to attract the highest at $648 million...
- MSCI India rejig: Why Adani Green, Groww and Laurus Labs are on investors’ radarAdani Green, Groww and Laurus Labs have emerged as key stocks to watch ahead of MSCI’s August 2026 index review. JM Financial expects up to...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities fell sharply as escalating West Asia tensions lifted crude oil prices and weakened the rupee, raising inflation concerns. S...
- Two Trades for Today: A top biopharma firm for a 7.55% gain, a private bank stock for a 6% upmoveOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Rs 1,839 crore Biocon block deal: ICICI Pru MF biggest buyer along with Citi and Goldman SachsMylan sold a ₹1,839 crore stake in Biocon through a block deal, attracting strong institutional demand. ICICI Prudential Mutual Fund emerge...
- Biocon among 4 midcap stocks that hit 52-week highs and rallied up to 21% in a monthDespite the Sensex falling 561 points on Tuesday, four BSE 150 Midcap stocks—The Phoenix Mills, Ipca Laboratories, Laurus Labs and Biocon—s...
- Biocon shares jump 6% as Mylan likely exits drugmaker after Rs 3,481 crore stake saleBiocon shares experienced a significant jump of over 6% on Tuesday. Viatris-owned Mylan intends to sell a substantial stake, exiting the In...
- Avenue Supermarts among 4 F&O stocks with sharp rise in futures open interestA sharp rise in futures open interest indicates a significant increase in the number of active, unexpired futures contracts in a stock.
- Stocks in news: Tata Elxsi, HCL Tech, ICICI Pru AMC, Biocon, SpiceJetIndian markets closed nearly unchanged after a volatile trading session on Monday. Tata Elxsi and L&T Tech shares are in focus as they anno...
- Mylan to sell up to $363 million stake in India's Biocon, term sheet showsMylan Inc plans to sell up to 92 million shares in Indian drugmaker Biocon Ltd, worth up to 34.81 billion Indian rupees ($363 million),...
Load More
